Pericardiocentesis Procedures Market Size, Share, and Industry Analysis, By Technique (Echocardiogram-guided Technique, Fluoroscopy-guided Technique, and Computed Tomography-guided Technique), By Indication (Infection, Inflammatory, Cancer, and Others), By Anatomical Site (Apical, Substernal, and Parasternal), By End-user (Cardiac Centers, Hospitals, and Others), and Regional Forecast, 2025-2032

Region : Global | Report ID: FBI110504 | Status : Ongoing

KEY MARKET INSIGHTS

The global pericardiocentesis procedures market is driven by the increasing incidences of pericardial effusion and cardiac tamponade. Various underlying conditions, including tuberculosis, pericardial infections, and chronic immune diseases, contribute to the rising prevalence of these conditions. The procedure is carried out using special designed kits.

For instance, in June 2022, the National Center for Biotechnology Information (NCBI) published an article that asymptomatic pericardial effusion was observed in more than 40.0% of individuals with Systemic lupus erythematosus (SLE).

Download Free sample to learn more about this report.

According to a study published by Izmirly et al. in 2021, which was the meta-analysis of the Centers for Disease Control and Prevention (CDC) data of 2018, the overall prevalence of SLE in the U.S. was 72.8 cases per 100,000.

Pericardiocentesis Procedures Market Driver

Rising Number of Cardiac Care Centers May Propel Market Growth

Pericardiocentesis procedures are typically performed by experienced cardiac specialists within well-equipped, controlled surgical settings, such as hospitals, cath labs, and cardiac care centers. Hence, the emergence of new cardiac care centers may account for the rising number of pericardiocentesis procedures, driving the market.

For instance, , Koninklijke Philips N.V. announced the launch of over 1500 cath labs in the Indian subcontinent. These cath labs are specifically designed to address the complex requirements of a variety of clinical procedures, such as cardiac intervention. The launch will contribute to the pericardiocentesis market expansion in Asia.

Pericardiocentesis Procedures Market Restraint

Risk of Procedure May Limit its Adoption Hindering Market Growth

Pericardiocentesis procedures depict some complications such as injury to the myocardium, pericardium hemorrhage, liver viscera, arrhythmia, and infection. The fear of these complications reduces the chances of patients opting for the procedure, which can hamper the pericardiocentesis procedures market growth.

For instance, in July 2023, according to an article published by NCBI, vasovagal bradycardia is one of the complications of pericardiocentesis procedures, which was observed in up to 25.0% of patients after acute decompression of the pericardial sac.

Pericardiocentesis Procedures Market Opportunity

Rising Awareness or Support May Contribute to Market Expansion

Organizations provide funds to aspiring practitioners specializing in pericardial disease management to develop new treatments for pericardial effusion, pericarditis, and others. The organization is also actively taking the initiative to educate people about the management of these diseases by creating a support group to encourage people to undergo pericardiocentesis procedures.

For instance, in August 2024, the Pericarditis Alliance funded USD 2,000 for 10 medical residents, students, or fellows to help with pericardial disease research.

Segmentation

By Technique	By Indication	By Anatomical Site	By End-user	By Region
Echocardiogram-guided Technique Fluoroscopy-guided Technique Computed Tomography-guided Technique	Infection Inflammatory Cancer Others	Apical Substernal Parasternal	Cardiac Centers Hospitals Others	North America (U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East and Africa (GCC, South Africa, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

Prevalence of Key Diseases, By Key Countries/Region, 2023
Number of Pericardiocentesis Procedures, By Key Countries, 2023
Overview: Advancements in Pericardiocentesis Procedures
Impact of COVID-19 on the Market

Analysis by Technique

By technique, the market is segmented into echocardiogram-guided technique, fluoroscopy-guided technique, and computed tomography-guided technique.

The echocardiogram-guided technique segment is expected to depict a moderate influence on the pericardiocentesis procedures market. The growth can be attributed to the preference for echocardiogram-guided pericardiocentesis. It is regarded as the primary approach due to its portability, enhanced safety, and accurate identification of the optimal needle entry site, such as substernal, apical, or parasternal.

For instance, in October 2020, an expert analysis published by the American College of Cardiology Foundation found that echocardiogram-guided pericardiocentesis can be safely performed in critical cases such as anticoagulation. The study reported a minimal bleeding rate of between 0.5% and 0.9%.

Analysis by Indication

By indication, the market is fragmented into infection, inflammatory, cancer, and others.

The infection segment is anticipated to contribute significantly to the market growth. The segmental expansion can be attributed to the incidences of pericardial effusion in tuberculosis, which is seen in developing countries, including Africa, India, and others.

For instance, in February 2022, according to an article published by NCBI, the frequency of cardiac tamponade in tuberculous pericarditis, a microbial infection of the pericardium, was approximately 7.0%, consecutively increasing the number of people undergoing pericardiocentesis procedure.

Analysis by Anatomical Site

By anatomical site, the market for pericardiocentesis procedures is categorized into apical, substernal, and parasternal.

The apical segment is expected to hold a substantial share due to the ease of direct access to the pericardium with minimal complications offered by the substernal approach. Additionally, this approach allows for feasible needle tracking, contributing to the overall segment growth.

For instance, in June 2021, an article published by the World Journal of Emergency Medicine suggested that the complication rate in the apical or parasternal approach was lower compared to the substernal approach.

Analysis by End-user

In terms of end-user, the market is fragmented into cardiac centers, hospitals, and others.

The cardiac centers segment is anticipated to experience lucrative growth during the forecast period. This growth is attributed to patients' preference for undergoing procedures at these facilities due to their state-of-the-art infrastructure and specialized services tailored to address a wide range of cardiac conditions, from diagnostics to treatment procedures.

For instance, in July 2023, as stated in a publication by the National Center for Biotechnology Information (NCBI), pericardiocentesis procedures should be exclusively conducted in a cardiac catheterization laboratory by a cardiologist and surgical team.

Analysis by Region

To gain extensive insights into the market, Download for Customization

By region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

The North America market is anticipated to experience substantial growth due to the rising number of people undergoing this procedure for underlying conditions such as pericardial infection and pericarditis.

For instance, in 2023, according to Cleveland Clinic, cardiologists in the U.S. performed over 29,000 pericardiocentesis procedures annually.

The Middle East & Africa market is set to expand owing to the high number of cases of tuberculosis. Severe tuberculosis causes pericardial effusion, which needs to be managed by a pericardiocentesis procedure. Hence, the demand for pericardiocentesis procedures in the region is increasing.

For instance, in February 2024, according to an article published by Springer Nature Limited, the incidence rate of tuberculosis in South Africa was recorded at 468 per 100,000 individuals in the year 2022.

In Asia Pacific, the market is expected to grow substantially over the forthcoming years due to the increasing number of cardiac catheterization laboratories performing the pericardiocentesis procedure in the region.

For instance, in July 2024, according to data published by Elsevier Ltd., the number of catheterization laboratories in Indonesia increased to approximately 310 between the years 2017 and 2022.

Key Players Covered

The report includes the profiles of the companies providing pericardiocentesis procedure and services.

Max Healthcare (India)
Cooperman Barnabas Medical Center (U.S.)
Cleveland Clinic (U.S.)
HCA Healthcare UK (U.K.)
Burjeel Hospital (UAE)
University of Ottawa Heart Institute (Canada)
Herzinstitut Berlin (Germany)
Heart Surgeon Melbourne (Australia)
Mulgrave Private Hospital (Australia)

Key Industry Developments

In April 2024, UCSF Health announced the launch of the construction of a new hospital called the UCSF Health Helen Diller Hospital. This planned hospital is anticipated to incorporate the latest technologies in robotics, diagnostics, and surgical procedures. The UCSF family offers the procedure of pericardiocentesis in their existing hospitals.
In June 2024, Méderi Hospital Network demonstrated a new approach for ultrasound-guided off-plane pericardiocentesis by anterior approach. This approach offers continuous needle tracking, reducing the risk of inadvertent cardiac puncture, pneumothorax, and LIMA in clinical settings.